文献速递消化系统肿瘤

肿瘤相关巨噬细胞分泌的抗菌肽cathelicidin促进小鼠结直肠癌生长

[Effect and mechanism of antimicrobial peptide cathelicidin secreted by tumor associated macrophage on the growth of colorectal cancer in mice].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2018-01-01

该研究采用AOM/DSS法建立小鼠肠炎相关结直肠癌模型,通过注射cathelicidin中和抗体观察其对肿瘤生长的影响。结果发现中和cathelicidin后肿瘤数目和长径显著减少,Ki-67阳性率降低,CD68表达下降,提示cathelicidin通过募集巨噬细胞促进结直肠癌增殖。

要点

  • 中和cathelicidin可显著减少小鼠结直肠癌肿瘤数目和大小。
  • cathelicidin中和抗体降低肿瘤组织Ki-67阳性率及CD68表达。
  • cathelicidin促癌作用可能与募集巨噬细胞至肿瘤微环境有关。

核心结论

  • 肿瘤相关巨噬细胞分泌的cathelicidin可促进小鼠结直肠癌生长,中和其活性可抑制肿瘤生长和增殖。

研究设计与样本

  • 采用AOM/DSS法建立小鼠肠炎相关结直肠癌模型,注射cathelicidin中和抗体、IgG抗体或PBS,持续1个月。

主要发现

  • cathelicidin中和抗体组肿瘤数目为(4.50±1.18)个,低于PBS组的(13.88±1.98)个和IgG组的(15.25±1.82)个,P<0.01。
  • cathelicidin中和抗体组肿瘤长径为(1.74±0.18)mm,低于PBS组的(3.74±0.38)mm和IgG组的(3.40±0.36)mm,P<0.01。
  • cathelicidin中和抗体组Ki-67阳性率为(28.20±3.44)%,低于PBS组的(68.20±3.51)%和IgG组的(69.20±3.41)%,P<0.01。
  • cathelicidin中和抗体组CD68表达明显低于IgG组和PBS组,TUNEL显示对肿瘤细胞凋亡影响不大。

临床怎么用

  • 该研究为小鼠临床前实验,cathelicidin中和策略尚未在人体验证,暂不能直接用于临床实践。

局限性

  • 研究仅在小鼠模型中进行,样本量未报告,结论外推至人类需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect and mechanism of the antibacterial peptide cathelicidin secreted by tumor associated macrophages on the growth of colorectal cancer in mice. Methods: Azoxymethane (AOM)/ dextran sodium sulfate (DSS) method was used to establish a mouse model of colitis associated colon cancer. To induce tumor formation, cathelicidin antibody, IgG antibody (positive control) or PBS (negative control) was respectively injected into mice once every 3 days and lasted one month. Then the pictures of mice colon were taken, and the numbers of tumor were counted and evaluated. Expressions of cathelicidin in tumor associated macrophages isolated from tumor and adjacent normal tissues of mice were examined by quantitative RT-PCR (qRT-PCR) and Western blot. Expressions of the tumor proliferating antigen Ki-67, macrophage marker CD68 and cathelicidin in tumor and non-tumor tissues were determined by immunohistochemistry analysis. Apoptosis of cells from tumor tissues was analyzed by using TdT-mediated dUTP nick-end labeling (TUNEL). Results: In colon tumor tissues, cathlicidin strongly expressed in inflammatory cells (macrophages), but weakly expressed in tumor cells. The tumor number and size in mice injected with cathelicidin neutralizing antibody were 4.50±1.18 and (1.74±0.18) mm, respectively, significantly lower than 13.88±1.98 and (3.74±0.38) mm of mice injected with PBS (t=4.07, t=4.72; P< 0.01) and 15.25±1.82 and (3.40±0.36) mm of mice injected with IgG antibody (t=4.96, t=4.08; P<0.01). The Ki-67 positive rate of cells in tumor tissues of mice injected with cathelicidin neutralizing antibody was (28.20±3.44) %, significantly lower than (68.20±3.51) % of mice injected with PBS (t=8.135, P<0.01) and (69.20±3.41) % of mice injected with IgG antibody (t=8.461, P<0.01). Immunohistochemistry analyses showed that the expression of CD68 in tumor tissues of mice injected with cathelicidin antibody was significantly lower than that of mice injected with IgG antibody or PBS. TUNEL result showed that treatment with cathelicidin neutralizing antibody had negligible effect on the apoptosis of tumor cells. Conclusions: Cathelicidin secreted by tumor associated macrophages can promote the growth of colorectal cancer in mice, and neutralizing cathelicidin activity can inhibit the growth and proliferation of colorectal cancer. Cathelicidin mediated promotion of colon cancer proliferation may mainly be exerted by recruiting inflammatory cells such as macrophages into the tumor microenvironment. 目的: 研究肿瘤相关巨噬细胞分泌的抗菌肽cathelicidin促进小鼠结直肠癌生长的作用及机制。 方法: 通过氧化偶氮甲烷/葡聚糖硫酸钠(AOM/DSS)方法建立小鼠肠炎相关的结直肠癌模型。对诱导成瘤的小鼠,同时每隔3 d注射1次小鼠cathelicidin中和抗体、IgG抗体(阳性对照)和PBS(阴性对照),持续1个月,取小鼠结肠,拍照、计数肿瘤数目并进行评价。利用实时荧光定量PCR和Western blot法检测小鼠结肠肿瘤组织、非肿瘤组织以及组织中巨噬细胞cathelicidin的表达;采用免疫组化法检测小鼠结肠肿瘤组织与非肿瘤组织中的cathelicidin、肿瘤增殖抗原Ki-67和CD68的表达;采用原位末端转移酶标记技术(TUNEL)检测小鼠结肠肿瘤组织中细胞的凋亡情况。 结果: cathelicidin在小鼠结肠肿瘤组织的炎症免疫细胞(巨噬细胞)中呈高表达状态,而在肿瘤细胞中表达较弱。注射cathelicidin中和抗体组小鼠的肿瘤数目和长径分别为(4.50±1.18)个和(1.74±0.18)mm,明显低于注射PBS组小鼠的肿瘤数目[(13.88±1.98)个,P<0. 01]和肿瘤长径[(3.74±0.38)mm,P<0. 01];也明显低于注射IgG抗体小鼠的肿瘤数目[(15.25±1.82)个,P<0. 01]和肿瘤长径[(3.40±0.36)mm,P<0.01]。注射cathelicidin中和抗体组肿瘤组织中Ki-67阳性肿瘤细胞百分比为(28.20±3.44)%,低于注射PBS组[(68.20±3.51)%,P<0.01]和注射IgG抗体组[(69.20±3.41)%,P<0.01]。免疫组织化学染色检测结果显示,注射cathelicidin中和抗体组小鼠组织中CD68的表达明显低于注射IgG抗体组和注射PBS组。TUNEL染色显示,注射cathelicidin中和抗体对肿瘤细胞的凋亡影响不大。 结论: 肿瘤相关巨噬细胞分泌的cathelicidin具有促进小鼠结直肠癌增殖的作用,中和cathelicidin的表达可以抑制结直肠癌的生长和增殖。cathelicidin通过募集炎症细胞(巨噬细胞)进入肿瘤微环境可能是其促进结直肠癌增殖的主要作用机制。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Quan WW, Pan XH, Wu JL, et al. [Effect and mechanism of antimicrobial peptide cathelicidin secreted by tumor associated macrophage on the growth of colorectal cancer in mice]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29575834. doi:10.3760/cma.j.issn.0253-3766.2018.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。